Preparation method and application of tedizolid phosphate for injection
By using a combination of phosphorylated sodium dextran and plulandosaccharide modified activated carbon to remove impurities, a three-dimensional structural network structure and etherification reaction was formed, and the preparation time and impurity content of lyophilized phosphate phosphate for injection was solved. The high problem achieves an efficient and low impurity preparation process and improves product quality.
Patent Information
- Application Number
- CN202411151027.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-26
AI Technical Summary
The existing preparation method for lyophilized phosphate preparation for injection takes a long time and has a high impurity content, making it difficult to simultaneously improve production efficiency and product quality.
The combination of phosphorylated dextran sodium solution and the Plurandosan modified activated carbon solution is used to remove impurities quickly by forming a three-dimensional structural network structure and etherification reaction, impurities are quickly adsorbed and precipitated, simplifying the preparation process and reducing the impurity content.
Significantly shorten the preparation time, improve production efficiency, significantly reduce the impurity content in special phosphate phosphate for injection, and improve product quality.
Smart Images

Figure BDA0005003667960000081 
Figure BDA0005003667960000091
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of pharmaceutical preparations, and in particular to a preparation method and application of tedizolid phosphate for injection. Background Art
[0002] Tedizolid phosphate is used to treat acute bacterial skin and skin tissue infections in adults. It is a prodrug of tedizolid. After oral or intravenous administration, it is converted into tedizolid by phosphatase. It is a new type of oxazolidinone precursor antibiotic. After entering the body, it is quickly converted into the microbiologically active group tedizolid under the action of phosphatase. Tedizolid is an oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome and exerts an antibacterial effect. It is not easy to produce cross-resistance with other types of antibiotics.
[0003] Patent CN202110023135.X discloses a method for preparing a lyophilized preparation of tedizolid phosphate for injection. The method for preparing the lyophilized preparation of tedizolid phosphate for injection comprises the following steps: a. Add tedizolid phosphate and a lyophilization protective agent to water for injection to obtain a tedizolid phosphate solution; b. Cool the solution to -8 to -10°C and -40 to -50°C in turn, and keep it for a specific time; then heat it to -15 to -10°C, and then cool it to -40 to -50°C, and keep it for a specific time to obtain a lyophilized product; c. Under vacuum conditions, heat the lyophilized product to -30 to -10°C and 40 to 50°C, and keep it for a specific time to obtain a lyophilized preparation of tedizolid phosphate for injection. The time cost of preparing a lyophilized preparation of tedizolid phosphate for injection is reduced, and a high-quality lyophilized preparation of tedizolid phosphate for injection with low impurities and moisture content can be obtained.
[0004] In the above patent, by setting three cooling and three heating processes, the lyophilized preparation of tedizolid phosphate for injection obtained by the final analytical drying forms a larger and uniform crystal form, thereby achieving the effect of improving the quality of the lyophilized preparation of tedizolid phosphate for injection. Although the quality of the lyophilized preparation of tedizolid phosphate for injection is improved to a certain extent in the above patent, it needs to go through three cooling and three heating processes, which takes a long time and leads to very low production efficiency. At present, no other document discloses a preparation method that can not only improve production efficiency but also reduce the impurity content in the prepared lyophilized preparation of tedizolid phosphate for injection. Summary of the invention
[0005] Based on the problem that the current preparation method of tedizolid phosphate for injection freeze-dried preparations in the background technology cannot simultaneously achieve efficient production and reduce the impurity content in the product, the object of the present invention is to provide a preparation method of tedizolid phosphate for injection. The tedizolid phosphate for injection prepared by the preparation method not only takes a short time, thereby achieving high production efficiency, but also has a low impurity content in the prepared tedizolid phosphate for injection freeze-dried preparation, and the product quality is high.
[0006] The present invention is achieved through the following technical solutions:
[0007] In a first aspect, the present application provides a method for preparing tedizolid phosphate for injection, comprising the following steps:
[0008] Step 1: adding tedizolid phosphate to water for injection, adding alkali solution dropwise until tedizolid phosphate is dissolved, and adjusting the pH to obtain tedizolid phosphate solution;
[0009] Step 2: adding an impurity remover to remove impurities in the tedizolid phosphate solution; the impurity remover is a combination of a phosphorylated sodium dextran solution and a pullulan-modified activated carbon solution; when used, first add the phosphorylated sodium dextran solution, stir until the solution becomes turbid or produces small flocs, and then add the pullulan-modified activated carbon solution until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without opalescence;
[0010] Step 3: The liquid after impurities removal in step 2 is placed in a static state for separation or centrifuged to obtain a clarified tedizolid phosphate solution;
[0011] Step 4: The clarified tedizolid phosphate solution is sequentially filled, semi-tamped, freeze-dried, and tamped to obtain tedizolid phosphate for injection.
[0012] In the impurity removal process of the preparation method of the present application, the phosphorylated sodium dextran solution firstly generates a framework connection structure network with the impurities in the tedizolid phosphate solution, so that the molecules rapidly increase, and the pullulan modified activated carbon solution then added further forms a three-dimensional structure network on the basis of the complex formed by the phosphorylated sodium dextran solution and the impurities in the tedizolid phosphate solution. The impurity remover of this structure can tightly adsorb the potential difference between the impurities in the tedizolid phosphate solution, and can quickly form a charged spherical floc within 10 minutes, breaking the original balance, while accelerating the Brownian motion between molecules, intensifying the collision between molecules, so that the small molecules of impurities that do not precipitate are combined into large molecules, and the mutual attraction between molecules produces flocculent precipitation. In addition, the active groups in the copolymer of sodium phosphorylated dextran and pullulan are significantly increased by an etherification reaction between sodium phosphorylated dextran and pullulan, and the pullulan-modified activated carbon solution is combined with the strong adsorption effect of sodium phosphorylated dextran, so that the composition has a strong removal effect on impurities in the tedizolid phosphate solution, thereby making the prepared tedizolid phosphate for injection have a low impurity content and a higher product quality. Moreover, the time required for preparing tedizolid phosphate for injection using the preparation method is shorter, and the production efficiency is higher.
[0013] Furthermore, the volume usage of the pullulan modified activated carbon solution is 1 to 1.3 times that of the phosphorylated sodium dextran solution.
[0014] Furthermore, the preparation method of the sodium dextran phosphorylation solution is: firstly, the sodium dextran phosphorylation is stirred into a paste using water, then water is added to swell the paste, and then the sodium dextran phosphorylation solution is obtained after stirring and filtering.
[0015] Furthermore, the concentration of the prepared sodium phosphorylated dextran solution is 1% to 2%.
[0016] Furthermore, the preparation method of the pullulan modified activated carbon solution is: adding acetic acid to pullulan, stirring into a paste, then adding acetic acid for swelling, stirring and filtering to obtain a pullulan solution, mixing activated carbon powder with the pullulan solution, and then using ultrasonic reaction to obtain a pullulan modified activated carbon solution.
[0017] Furthermore, the concentration of the prepared pullulan solution is 1% to 2%.
[0018] Furthermore, the mass ratio of the activated carbon powder to the pullulan solution is (1-2):1.
[0019] Furthermore, the alkali solution in step 1 includes sodium hydroxide or potassium hydroxide.
[0020] Furthermore, in step 1, the pH value is adjusted to 1-3.
[0021] In a second aspect, the present application provides an application of tedizolid phosphate for injection prepared by any one of the above-mentioned preparation methods, including use for preparing tedizolid phosphate for injection lyophilized agent or tedizolid phosphate for injection powder injection.
[0022] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0023] In the present application, an impurity remover is used to remove impurities from the tertiary phosphate for injection in the preparation process. Compared with the traditional cooling and heating methods, this method has the advantages of short time consumption and high production efficiency, and an etherification reaction can occur between the phosphorylated dextran sodium solution and the pullulan modified activated carbon solution used in the impurity remover, so that the active groups of the copolymer are more, thereby enhancing the adsorption of impurities in the tertiary phosphate solution by the impurity remover and improving the purification effect. At the same time, the method of first adding the phosphorylated dextran sodium solution and then adding the pullulan modified activated carbon solution is adopted, so that the impurity remover can form a three-dimensional network structure with strong adsorption, and through the combined action of more active groups and the three-dimensional network structure, the impurity remover can quickly and thoroughly adsorb the impurities in the tertiary phosphate for injection, thereby improving the production efficiency and improving the quality of the product. DETAILED DESCRIPTION
[0024] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.
[0025] Therefore, the detailed description of the embodiments of the present invention provided below is not intended to limit the scope of the claimed invention, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0026] Example 1
[0027] This embodiment provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, wherein the preparation method of the impurity remover is:
[0028] 1) Preparation of sodium dextran phosphate solution: 100 g of sodium dextran phosphate was weighed, mixed with water, stirred to a paste, and then water was added to swell the mixture to prepare a sodium dextran phosphate solution with a concentration of 1.5%.
[0029] 2) Preparing a pullulan-modified activated carbon solution: weighing 100 g of pullulan, adding acetic acid with a concentration of 2%, stirring into a paste, then adding acetic acid with a concentration of 2% for swelling, stirring and filtering to obtain a pullulan solution with a concentration of 1.5%; mixing the activated carbon powder with the prepared pullulan solution in a mass ratio of 1.5:1, using an ultrasonic reaction at a frequency of 1500 MHz for 8 minutes, and then using an ultrasonic reaction at a frequency of 8000 MHz for 8 minutes to obtain a pullulan-modified activated carbon solution.
[0030] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0031] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0032] S2. First, add 10 ml of 1.5% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1.5%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0033] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0034] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-stoppered, freeze-dried, and stoppered to obtain tedizolid phosphate for injection.
[0035] Example 2
[0036] This example provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, which is different from Example 1 in that the concentration of the phosphorylated dextran sodium solution in the impurity remover prepared in this example is 1%, and the concentration of the pullulan solution is the same as in Example 1, which is 1%. The preparation methods of both are the same as in Example 1.
[0037] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0038] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0039] S2. First, add 10 ml of 1% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0040] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0041] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-stoppered, freeze-dried, and stoppered to obtain tedizolid phosphate for injection.
[0042] Example 3
[0043] This embodiment provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, which is different from that in Example 1 in that the concentration of the phosphorylated dextran sodium solution in the impurity remover prepared in this embodiment is 2%, and the concentration of the pullulan solution is the same as that in Example 1, which is 2%. The preparation methods of both are the same as those in Example 1.
[0044] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0045] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0046] S2. First, add 10 ml of 2% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 2%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0047] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0048] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-stoppered, freeze-dried, and stoppered to obtain tedizolid phosphate for injection.
[0049] Example 4
[0050] This embodiment provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, which is different from that in Example 1 in that the concentration of the phosphorylated dextran sodium solution in the impurity remover prepared in this embodiment is 1%, and the concentration of the pullulan solution is the same as in Example 1, which is 2%. The preparation methods of both are the same as in Example 1.
[0051] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0052] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0053] S2. First, add 10 ml of 1% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 2%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0054] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0055] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0056] Example 5
[0057] This embodiment is a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, which is different from that in Example 1, when the impurity remover in this embodiment is used to prepare the pullulan modified activated carbon solution, the activated carbon powder is mixed with the prepared pullulan solution at a mass ratio of 1:1. Other technical features are the same as those in Example 1.
[0058] The specific preparation method of pullulan modified activated carbon solution is:
[0059] Weigh 100g of pullulan, add acetic acid with a concentration of 2%, stir into a paste, then add acetic acid with a concentration of 2% for swelling, stir and filter to obtain a pullulan solution with a concentration of 1.5%; mix the activated carbon powder and the prepared pullulan solution in a mass ratio of 1:1, react with ultrasound at a frequency of 1500MHz for 8 minutes, and then react with ultrasound at a frequency of 8000MHz for 8 minutes to obtain a pullulan-modified activated carbon solution.
[0060] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0061] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0062] S2. First, add 10 ml of 1.5% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1.5%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0063] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0064] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-stoppered, freeze-dried, and stoppered to obtain tedizolid phosphate for injection.
[0065] Example 6
[0066] This embodiment is a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover, which is different from that in Example 1, when the impurity remover in this embodiment is used to prepare the pullulan modified activated carbon solution, the activated carbon powder is mixed with the prepared pullulan solution at a mass ratio of 2:1. Other technical features are the same as those in Example 1.
[0067] The specific preparation method of pullulan modified activated carbon solution is:
[0068] Weigh 100g of pullulan, add acetic acid with a concentration of 2%, stir into a paste, then add acetic acid with a concentration of 2% for swelling, stir and filter to obtain a pullulan solution with a concentration of 1.5%; mix the activated carbon powder and the prepared pullulan solution in a mass ratio of 2:1, react with ultrasound at a frequency of 1500MHz for 8 minutes, and then react with ultrasound at a frequency of 8000MHz for 8 minutes to obtain a pullulan-modified activated carbon solution.
[0069] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0070] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0071] S2. First, add 10 ml of 1.5% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1.5%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0072] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0073] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0074] Example 7
[0075] This embodiment provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover. Different from Example 1, when preparing tedizolid phosphate for injection in this embodiment, the volume of the added phosphorylated sodium dextran solution is 10 ml, and the volume of the added pullulan-modified activated carbon solution is also 10 ml.
[0076] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0077] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0078] S2. First, add 10 ml of 1% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 10 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0079] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0080] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0081] Example 8
[0082] This embodiment provides a method for preparing tedizolid phosphate for injection, using a pre-prepared impurity remover. Different from Example 1, when preparing tedizolid phosphate for injection in this embodiment, the volume of the added phosphorylated sodium dextran solution is 10 ml, and the volume of the added pullulan-modified activated carbon solution is also 12 ml.
[0083] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0084] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0085] S2. First, add 10 ml of 1% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 12 ml of pullulan modified activated carbon solution (the concentration of the pullulan solution used is 1%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0086] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0087] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-stoppered, freeze-dried, and stoppered to obtain tedizolid phosphate for injection.
[0088] Comparative Example 1
[0089] This comparative example is a method for preparing tedizolid phosphate for injection, in which the impurity remover used only includes phosphorylated sodium dextran solution. The preparation method of the phosphorylated sodium dextran solution is the same as that of Example 1.
[0090] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0091] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0092] S2. Add 23 ml of 1.5% sodium dextran phosphate solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then let it stand until the supernatant is transparent without floating light.
[0093] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0094] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0095] Comparative Example 2
[0096] This comparative example is a method for preparing tedizolid phosphate for injection, in which the impurity remover used is only pullulan modified activated carbon solution, and the preparation method of the pullulan modified activated carbon solution is the same as that of Example 1.
[0097] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0098] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0099] S2. Add 23 ml of pullulan-modified activated carbon solution (the concentration of the pullulan solution used is 1.5%) to the tedizolid phosphate solution until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0100] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0101] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0102] Comparative Example 3
[0103] The comparative example is a method for preparing tedizolid phosphate for injection, in which the pullulan in the impurity remover used is not subjected to pullulan-modified activated carbon, but directly uses only the pullulan solution.
[0104] The preparation method of plandusaccharide solution is as follows:
[0105] Weigh 100 g of pullulan, add 2% acetic acid, stir to form a paste, then add 2% acetic acid to swell, stir and filter to obtain a 1.5% pullulan solution.
[0106] The impurity remover is used to prepare tedizolid phosphate for injection, and the specific method is as follows:
[0107] S1. Add 1000 g of tedizolid phosphate to water for injection, add a 1 mol / L sodium hydroxide solution dropwise until the tedizolid phosphate is dissolved, and adjust the pH to 2 to obtain a tedizolid phosphate solution.
[0108] S2. First, add 10 ml of 1.5% sodium phosphated dextran solution to the tedizolid phosphate solution, stir until the solution becomes turbid or produces small flocs, and then add 13 ml of pullulan solution (the concentration of the pullulan solution used is 1.5%) until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without floating light.
[0109] S3. Centrifuge the liquid after the impurity removal to obtain a clarified tedizolid phosphate solution.
[0110] S4. The clarified tedizolid phosphate liquid is sequentially filled, semi-plugged, freeze-dried, and plugged to obtain tedizolid phosphate for injection.
[0111] The total impurities in the tedizolid phosphate for injection prepared by the methods of Examples 1 to 8 and Comparative Examples 1 to 3 were detected by HPLC, wherein samples were taken at 25°C for detection on day 0, 3 months, and 6 months, and the detection results are shown in Table 1; samples were taken at 60°C for detection on day 0, 5 days, and 10 days, and the detection results are shown in Table 2.
[0112] Table 1
[0113]
[0114]
[0115] Table 2
[0116] project 0 days (total impurity content) 5 days (total impurity content) 10 days (total impurity content) Example 1 0.18% 0.21% 0.27% Example 2 0.19% 0.22% 0.30% Example 3 0.18% 0.23% 0.31% Example 4 0.18% 0.22% 0.30% Example 5 0.20% 0.24% 0.29% Example 6 0.19% 0.22% 0.31% Example 7 0.19% 0.23% 0.29% Example 8 0.20% 0.23% 0.30% Comparative Example 1 0.43% 0.55% 0.70% Comparative Example 2 0.39% 0.51% 0.68% Comparative Example 3 0.31% 0.48% 0.64%
[0117] The prepared tedizolid phosphate for injection in the embodiment and the comparative example is tested under a temperature condition higher than that of the conventional storage environment. It can be seen from the data obtained therein that the impurity content in the tedizolid phosphate for injection prepared by the method in the embodiment of the present application is lower than that in the comparative example, which illustrates that the impurity removal agent in the present application can better remove impurities in the product. At the same time, by comparison, it is also proved that the impurity removal agent in the present application requires a combination of the two to achieve a better impurity removal effect. At the same time, the overall time consumption of the preparation method in the present application is also short, so that the production efficiency of tedizolid phosphate for injection is higher. In addition, by detecting the impurity content in tedizolid phosphate for injection in a manner of a period of time at intervals under the temperature conditions of 30°C and 60°C respectively, it is also proved that the stability of tedizolid phosphate for injection prepared by the preparation method of the present application is high.
[0118] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A method for preparing tedizolid phosphate for injection, characterized in that: The following steps are involved: Step 1: adding tedizolid phosphate to water for injection, adding alkali solution dropwise until tedizolid phosphate is dissolved, and adjusting the pH to obtain tedizolid phosphate solution; Step 2: adding an impurity remover to remove impurities in the tedizolid phosphate solution; the impurity remover is a combination of a phosphorylated sodium dextran solution and a pullulan-modified activated carbon solution; when used, first add the phosphorylated sodium dextran solution, stir until the solution becomes turbid or produces small flocs, and then add the pullulan-modified activated carbon solution until there are obvious flocs in the tedizolid phosphate solution and the supernatant is transparent without opalescence; Step 3: The liquid after impurities removal in step 2 is placed in a static state for separation or centrifuged to obtain a clarified tedizolid phosphate solution; Step 4: The clarified tedizolid phosphate solution is sequentially filled, semi-tamped, freeze-dried, and tamped to obtain tedizolid phosphate for injection.
2. The method for preparing tedizolid phosphate for injection according to claim 1, characterized in that: The volume usage of the pullulan modified activated carbon solution is 1 to 1.3 times that of the phosphorylated sodium dextran solution.
3. The method for preparing tedizolid phosphate for injection according to claim 1, characterized in that: The preparation method of the sodium dextran phosphorylation solution is as follows: firstly, the sodium dextran phosphorylation is stirred into a paste by using water, then water is added to swell the mixture, and the sodium dextran phosphorylation solution is obtained after stirring and filtering.
4. The method for preparing tedizolid phosphate for injection according to claim 3, characterized in that: The concentration of the prepared sodium phosphorylated dextran solution is 1% to 2%.
5. The method for preparing tedizolid phosphate for injection according to claim 1, characterized in that: The preparation method of the pullulan modified activated carbon solution is as follows: adding acetic acid to pullulan, stirring into a paste, then adding acetic acid for swelling, stirring and filtering to obtain a pullulan solution, mixing activated carbon powder with the pullulan solution, and then using ultrasonic reaction to obtain a pullulan modified activated carbon solution.
6. The method for preparing tedizolid phosphate for injection according to claim 5, characterized in that: The concentration of the prepared pullulan solution is 1% to 2%.
7. The method for preparing tedizolid phosphate for injection according to claim 5, characterized in that: The mass ratio of the activated carbon powder to the pullulan solution is (1-2):
1.
8. The method for preparing tedizolid phosphate for injection according to claim 1, characterized in that: The alkali solution in step 1 includes sodium hydroxide or potassium hydroxide.
9. The method for preparing tedizolid phosphate for injection according to claim 1, characterized in that: In step 1, the pH value is adjusted to 1-3.
10. Use of tedizolid phosphate for injection prepared by the preparation method according to any one of claims 1 to 9, characterized in that: Including preparation of tedizolid phosphate lyophilized preparation for injection or tedizolid phosphate powder for injection.
